Disorders associated with reduced gastrointestinal motility
Adult: As anhydrous citrate: 5 mg tid.
                                            | 
                                         
Indications and Dosage
                                             
                                            
Oral 
                                        Disorders associated with reduced gastrointestinal motility Adult: As anhydrous citrate: 5 mg tid. 
                                             | 
                                
| 
                                         
Special Precautions
                                             
                                            
Continuous admin of this drug is not recommended if no improvement in GI symptoms is observed after 2 wk of admin. Elderly, renal impairment, hepatic impairment.
                                             
                                         | 
                                
| 
                                         
Adverse Reactions
                                             
                                            
Diarrhoea, abdominal pain; dizziness; constipation; headache; insomnia; nausea. 
                                         | 
                                
| 
                                         
Drug Interactions
                                             
                                            
Mosapride concentration increased by erythromycin. May increase risk of QT prolongation with QT prolonging drugs. 
                                         | 
                                
| 
                                         
Action
                                             
                                            
Description:  
                                        Mechanism of Action: Mosapride is a 5-HT4 receptor agonist which increases the release of acetylcholine and stimulates GI motility. It also has 5-HT3 antagonist properties.  |